Antibiotic Resistance News and Research

RSS

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Bacterial infectious diseases are still a huge contributor to global disease burden and with antibiotic resistance on the rise worldwide there is an urgent need for novel treatment strategies against bacteria.

14 Oct 2022

Sewage monitoring method detects hepatitis virus in wastewater samples

Researchers in Sweden have created a method that now makes it possible to monitor sewage for a virus that has is believed to be linked to hepatitis outbreaks worldwide.

13 Oct 2022

DTU researchers create a new tool in the fight against resistant bacteria

According to the WHO, antibiotic resistance is one of the biggest threats to public health. DTU researchers have created a new tool in the fight against resistant bacteria that, based on 214,000 microbiome samples, can create an overview of the problem across countries, people and environments.

13 Oct 2022

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments - a threat that has been met with insufficient funding and dwindling inspiration, as commercial incentives for developing new antibiotics have fallen.

13 Oct 2022

Early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis begins

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs.

4 Oct 2022

Study identifies potential therapeutic targets for preventing aminoglycoside-induced hearing loss

Researchers at Indiana University School of Medicine are developing new ways to study why an antibiotic causes hair cell death and permanent hearing loss in people.

27 Sep 2022

New engineered peptides could prevent the superbug crisis

A recent study reports the development of a synthetic antibacterial peptide PLG0206.

22 Sep 2022

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

Researchers evaluated the association between guild-level microbiome signature and the severity and prognosis of SARS-CoV-2 infections by a genome-level metagenomic analysis.

21 Sep 2022

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.

6 Sep 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

Research receives NSF funding to fight against medical device infections

When Martha Grady tells her students about her research, she describes it as "shooting lasers at stuff to see what happens."

26 Aug 2022

Study shows how Klebsiella pneumoniae suppresses the body's defenses

New research published in Cell Reports has shown how the bacterium Klebsiella pneumoniae suppresses our body's defences, resulting in it being unable to clear infection.

24 Aug 2022

What is the prevalence of bacterial co-infections during COVID-19?

Researchers evaluated the characteristics and prevalence of bacterial co-infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Aug 2022

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

Researchers developed an epidemiological model to simulate the co-circulation of SARS-CoV-2 and multidrug-resistant bacteria in healthcare facilities during the early phase of the COVID-19 pandemic.

18 Aug 2022

Scientists elucidate the structure of Type IV secretion system involved in antibiotic resistance

With antibiotic-resistant bacteria on the rise, scientists have been searching for ways to shut down the Type IV secretion system (T4SS), a protein complex on the outer envelope of bacterial cells that helps them to exchange DNA with neighboring bacteria and resist antibiotics.

17 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

Antibiotic Resistance News and Research

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Sewage monitoring method detects hepatitis virus in wastewater samples

DTU researchers create a new tool in the fight against resistant bacteria

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis begins

Study identifies potential therapeutic targets for preventing aminoglycoside-induced hearing loss

New engineered peptides could prevent the superbug crisis

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

Research receives NSF funding to fight against medical device infections

Study shows how Klebsiella pneumoniae suppresses the body's defenses

What is the prevalence of bacterial co-infections during COVID-19?

Mathematical model describes the simultaneous transmission of SARS-CoV-2 and multidrug-resistant bacteria

Scientists elucidate the structure of Type IV secretion system involved in antibiotic resistance

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

How did the COVID-19 pandemic impact the epidemiology of antibiotic resistant bacteria?

New method can modify an entire substance class of medically relevant natural products

Early-life acquisition of antibiotic resistance in neonates from developing countries

What is the prevalence of carbapenem-resistant Enterobacterales among individuals with and without health risk factors?

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy